Search Results - Imeraj, Amantia

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

    Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 by Leone, Valentina Fanny, Imeraj, Amantia, Gastoldi, Sara, Mele, Caterina, Liguori, Lucia, Condemi, Carmelita, Ruggenenti, Piero, Remuzzi, Giuseppe, Carrara, Camillo

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    1196 C3G and ic-MPGN across the life span: findings from the European Rare Kidney Disease Registry

    1196 C3G and ic-MPGN across the life span: findings from the European Rare Kidney Disease Registry by Schaefer, Franz, Hofstetter, Jonas, Ruiz, Enrique Morales, Antonucci, Luca, Conlon, Peter J, Francesca, Becherucci, Servais, Aude, Kanzelmeyer, Nele, Beltran, Victor Perez, Imeraj, Amantia, Mastrangelo, Antonio, Roccatello, Dario

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

    Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19 by Leone, Valentina Fanny, Imeraj, Amantia, Gastoldi, Sara, Mele, Caterina, Liguori, Lucia, Condemi, Carmelita, Ruggenenti, Piero, Remuzzi, Giuseppe, Carrara, Camillo

    Get full text
    Report
    Save to List
    Saved in:

Search Tools: